RA
AMGN icon

Resolute Advisors’s Amgen AMGN Stock Holding History

Resolute Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-118
Closed -$25K – 198
2021
Q3 		$25K Sell
118
-12
-9% -$2.76K ﹤0.01% 202
2021
Q2 		$32K Hold
130
– – ﹤0.01% 124
2021
Q1 		$29K Buy
130
+115
+767% +$27.4K ﹤0.01% 107
2020
Q4 		$3K Buy
+15
New +$3.46K ﹤0.01% 71

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Resolute Advisors's AMGN Position: Q4 2021 in Review

Resolute Advisors sold out of Amgen (AMGN) in Q4 2021, closing a stake of 118 shares — an estimated $25K sold.

Resolute Advisors first reported a position in AMGN in Q4 2020 and held it in 4 quarters. The position peaked at $32K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Resolute Advisors reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Resolute Advisors sold 118 Amgen shares in Q4 2021, an estimated $25K.
  • Resolute Advisors first reported a position in Amgen in Q4 2020 and held it in 4 quarters.
  • Resolute Advisors's Amgen position peaked at $32K in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.